Richard Twoy
Licensed Practical Nurse · San Jose, CANPI 1174641526
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,922 and has fallen 63.8% since, to $696 in 2025. Among licensed practical nurse clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $116.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$681
- AstraZeneca$660
- Paratek Pharmaceuticals, Inc.$492
- AbbVie$489
- GSK$480
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$368
- plus $3K from 15 others
What the payments were for
- Food & beverage$5,703100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 5 | $681 |
| AstraZeneca | 6 | $660 |
| Paratek Pharmaceuticals, Inc. | 4 | $492 |
| AbbVie | 5 | $489 |
| GSK | 4 | $480 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $368 |
| Eisai Inc. | 3 | $314 |
| Neurocrine Biosciences, Inc. | 2 | $251 |
| Gilead | 2 | $246 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $222 |
| Fresenius Kabi USA, LLC | 2 | $215 |
| Novo Nordisk | 2 | $214 |
| Genentech USA, Inc. | 1 | $148 |
| Bayer | 1 | $137 |
| IBSA Pharma Inc. | 1 | $125 |
| Dexcom, Inc. | 1 | $122 |
| Karyopharm Therapeutics Inc. | 1 | $122 |
| Argenx US, Inc. | 1 | $110 |
| Abbott | 1 | $103 |
| Biogen | 1 | $102 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $101 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,703 in reported general payments places this provider in the 95th percentile of 28 licensed practical nurse providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin Hcl | 19 | $323 |
Paid to pharmacies, not to this prescriber.
Other licensed practical nurse in San Jose
- Leslie ClarkSan Jose$23
- Maryam AhmadianBeverly Hills$3K
- Samrang SchimelpfenigSan Diego$3K
- Farnoush KarimpourVisalia$1K
- Nastaran MinassiansLos Angeles$1K
- Jayne SmithSeal Beach$1K
- Rosa LeeSan Francisco$353
- Christy Henderson PetersonStockton$325
- Harold GomezWest Covina$280
- Leslie ReynoldsSan Diego$240
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.